CLINICAL TRIALS IN EUROPE
24 Jun2020
STATUS OF CLINICAL TRIALS
Europe
Max Planck Institute and Free University of Berlin (Germany) and University of Copenhagen (Denmark)
Effective and affordable treatments are needed for COVID-19 patients. We report the in vitro efficacy of Artemisia annua extracts as well as artemisinin, artesunate and artemether against CoV-2-SARS. The last two are approved active pharmaceutical ingredients for antimalarial drugs. (...) Clinical studies are needed to better assess the usefulness of these compounds as a treatment for COVID-19.
Sources:
https://www.biorxiv.org/content/10.1101/2020.10.05.326637v1 (pre-publication, October 5, 2020)
Pdf: https://www.biorxiv.org/content/10.1101/2020.10.05.326637v1.full.pdf